CLuB Presents at the EACR-AACR-IACR 2024 International Conference in the Dublin Convention Centre
The European Association for Cancer Research (EACR) and American Association for Cancer Research (AACR), in collaboration with the Irish Association for Cancer Research (IACR), held their Basic and Translational Research Conference this year in the Dublin Convention Centre. The Joint Conference, which focused on bringing the latest discoveries from basic science to the clinic, was held from February 27th to 29th, 2024.
Throughout the conference, the inspiring team of CLuB (research scientists, clinicians, research nurses, and senior technicians) presented their cancer research to an audience of basic and translational scientists and clinicians.
On February 28th, CLuB Founder and Lead Investigator Professor Lorraine O’Driscoll delivered an Invited talk entitled “Cancer Liquid Biopsies: Investigating the Sum of Their Parts for Patients' Benefit.” This fantastic talk provided a complete overview of the power of liquid biopsy in many different cancers, including the pioneering research at Trinity College Dublin’s School of Pharmacy and Pharmaceutical Sciences and TSJCI.
Ms Faye Lewis, PhD candidate under the mentorship of Dr Sharon O’Toole, presented her poster “Longitudinal detection of circulating tumour cells in epithelial ovarian cancer” in the spotlight.
Dr Krisztián Belényesi MD, PhD candidate under the supervision of Professor Lorraine O’Driscoll, presented his poster "Extracellular vesicles in liquid biopsies: investigating ways of collecting extracellular vesicles of a range of sizes using approaches that may have clinical utility".
Ms Volga Saini, PhD candidate under the supervision of Dr Kathy Gately, presented her poster “Comparison of Different Circulating Tumour Cell (CTC) Enrichment Technologies in Patients with Resectable Lung Cancer".
Dr Alexander McIntyre, CLuB’s postdoctoral researcher at Queen’s University Belfast presented his poster “Extracellular vesicles in liquid biopsies: investigating ways of collecting extracellular vesicles of a range of sizes using approaches that may have clinical utility", and Mr Michael Ryan, also from Queens’ University Belfast presented his poster “Liquid Biopsy – A game changer in the clinical management of Ovarian Cancer?” at the event.
CLuB’s esteemed colleague Dr Mark Ward also delivered a talk on “The Prognostic significance of circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) in high-grade serous ovarian cancer.”